Skip to main navigation Skip to search Skip to main content

Diabetes mellitus downregulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy

  • Jiunn Jye Sheu
  • , Tzu Hsien Tsai
  • , Li Teh Chang
  • , Chiang Hua Chiang
  • , Ali A. Youssef
  • , Cheuk Kwan Sun
  • , Nyuk Kong Chang
  • , Hon Kan Yip*
  • *Corresponding author for this work
  • Chang Gung University
  • Meiho University
  • National Pingtung University of Science and Technology
  • Suez Canal University
  • Chang Gung Memorial Hospital

Research output: Contribution to journal › Journal Article › peer-review

6 Scopus citations

Abstract

Background: Diabetes mellitus (DM) plays a crucial role in the pathogenesis of initiation and propagation of atherosclerosis. Although previous studies have suggested that interactions between cells form the framework for understanding the pathogenesis of atherosclerosis, little is known about how DM impacts intercellular communication within arteries, which occurs via connexin43 (Cx43) gap junctions (GJs). This study tested the hypothesis that DM suppresses expression of Cx43 GJs, and that this suppression can be abrogated via simvastatin or losartan treatment. Methods: An experimental model of DM (induced by streptozocin 60 mg/kg body weight) in adult male rats (n = 24) was utilized to investigate Cx43 expression in the aorta. These rats were divided into group I (insulin therapy only), group II (insulin plus simvastatin 20 mg/kg/day) and group III (insulin plus losartan 20 mg/kg/day). Twenty-four diabetic rats and 8 healthy rats (group IV) were sacrificed 3 weeks after DM induction for Western blot and immunofluorescence analysis. Results: By day 21, the blood sugar level was significantly higher than the respective baseline values in groups I, II and III (all values of p < 0.0001). Additionally, the final blood sugar levels of groups I-III were significantly higher than that of group IV (p < 0.0001). The final body weight in group IV was significantly higher than that in groups I-III (all values of p < 0.0001). Experimental results demonstrated that Cx43 expression in the aortic wall did not differ among groups II-IV (p > 0.1). However, compared with groups II-IV, Cx43 expression in the aortic wall was significantly mitigated in group I (all values of p < 0.05). Western blot results showed that relative density of Cx43 to β-actin was significantly higher in groups II-IV than in group I (p < 0.01). Conclusions: DM markedly suppressed expression of Cx43 in rat aortic walls. Both simvastatin and losartan treatment significantly reversed the effects of DM on integrity of Cx43 expression.

Original languageEnglish
Pages (from-to)136-144
Number of pages9
JournalChang Gung Medical Journal
Volume31
Issue number2
StatePublished - 03 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Connexin43
  • Diabetes mellitus
  • Pharmacomodulation

Fingerprint

Dive into the research topics of 'Diabetes mellitus downregulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy'. Together they form a unique fingerprint.

Cite this